Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs), a class of glucose-lowering drugs, have demonstrated a wide range of pleiotropic effects that extend beyond glycaemic control
GLP-1 Microdosing, Brain Health, and Alzheimers Prevention: What the Evidence Actually Shows AI Overview GLP-1 medications such as semaglutide and tirzepatide are being studied for more than weight loss
Thats my family
Originally developed for type 2 diabetes, these drugs have now proven to be some of the most powerful tools for sustainable weight loss
Though still in its infancy in GLP-1 manufacturing, R&D teams in other modalitiessuch as oligonucleotidesare already piloting this concept
But one researcher, John Cawley, a professor of economics and public policy at Cornell University, and his colleagues found that while obesity basically doubles a persons annual health care costs, the savings associated with public insurance plans covering GLP-1s for just obesity treatment are dependent on the patients starting body mass index, or BMI